ROBERTO BOLLI, MD
Osteopathic Medicine in Louisville, KY
License number
Kentucky 31035
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
201 Abraham Flexner Way 1001, Louisville, KY 40202
Phone
(502) 587-4500
(502) 587-4146 (Fax)
(502) 589-4856
(502) 589-5093 (Fax)
(502) 587-4146 (Fax)
(502) 589-4856
(502) 589-5093 (Fax)
Personal information
See more information about ROBERTO BOLLI at radaris.comName
Address
Phone
3450 Woodside Rd, Louisville, KY 40222
3450 Woodside Rd, Louisville, KY 40222
Organization information
See more information about ROBERTO BOLLI at bizstanding.comRoberto Bolli MD,PHD
201 Abraham Flexner Way, Louisville, KY 40202
Industry:
Internist
Phone:
(502) 584-8563 (Phone)
Roberto Bolli
Professional information
Roberto Bolli, Louisville KY
Specialties:
Internist
Address:
201 Abraham Flexner Way, Louisville, KY 40202
Education:
University of Perugia, Faculty of Medicine and Surgery - Doctor of Medicine
Baylor Clinic & Hospital - Fellowship - Cardiology
National Institutes of Health-Clinical Center - Residency - Cardiology
Baylor Clinic & Hospital - Fellowship - Cardiology
National Institutes of Health-Clinical Center - Residency - Cardiology
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
Professor Of Medicine At University Of Louisville
Position:
Professor of Medicine at University of Louisville
Location:
Louisville, Kentucky Area
Industry:
Research
Work:
University of Louisville
-
Professor of Medicine
Roberto Bolli, Louisville KY
Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
University Medical Assoc
201 A Flexner Way, Louisville, KY 40202
201 A Flexner Way, Louisville, KY 40202
Education:
Universita Degli Studi Di Perugia (1976) *, National Institute of Health *Cardiology
Cardiac Myocyte Morphogenic Compositions And Methods Of Use Therefor
US Patent:
2011005, Mar 3, 2011
Filed:
Feb 26, 2009
Appl. No.:
12/919648
Inventors:
Michael Patrick Flaherty - Louisville KY, US
Buddhadeb Dawn - Missiion Hills KS, US
Roberto Bolli - Louisville KY, US
Buddhadeb Dawn - Missiion Hills KS, US
Roberto Bolli - Louisville KY, US
International Classification:
A61K 35/28, C12N 5/071, C12N 5/10, C12M 3/00, A61P 9/10, A61P 9/00
US Classification:
424 937, 435377, 435325, 435366, 435370, 4352891
Abstract:
Disclosed are methods for inducing cardiomyogenic differentiation in cells that are competent for differentiation along the cardiomyogenic lineage such as certain unfractionated bone marrow mononuclear cells (BMMNCs). In some embodiments, the methods include contacting a plurality of unfractionated, density gradient-separated BMMNCs with a cardiomyocyte differentiation-inducing amount of a Wnt11 gene product for a time and under conditions sufficient to induce cardiomyocyte differentiation in at least a subset of the BMMNCs. Also provided are methods for treating an injury to cardiac tissue in a subject using cells that have been induced to differentiate along the cardiomyogenic lineage, recombinant host cells comprising an expression vector that encodes a Wnt11 polypeptide or a functional fragment thereof, and systems for inducing cardiomyogenic differentiation in a cultured cell.
Subpopulations Of Bone Marrow-Derived Adherent Stem Cells And Methods Of Use Therefor
US Patent:
2009011, Apr 30, 2009
Filed:
Oct 30, 2008
Appl. No.:
12/261344
Inventors:
Buddhadeb Dawn - Louisville KY, US
Ahmed Abdel-Latif - Lexington KY, US
Roberto Bolli - Louisville KY, US
Ahmed Abdel-Latif - Lexington KY, US
Roberto Bolli - Louisville KY, US
Assignee:
The University of Louisville Research Foundation, Inc. - Louisville KY
International Classification:
A61K 35/12, C12N 5/06
US Classification:
424 937, 435378, 435325
Abstract:
The presently disclosed subject matter provides an isolated subpopulation of bone marrow-derived adherent stem cells that are purified from bone marrow-derived adherent cells. Also provided are methods for isolating the subpopulation of bone marrow-derived adherent stem cells from bone marrow-derived adherent cells and for using the isolated subpopulation of bone marrow-derived adherent stem cells for treating tissue and/or organ damage in a subject.
Uses And Isolation Of Very Small Of Embryonic-Like (Vsel) Stem Cells
US Patent:
2009015, Jun 18, 2009
Filed:
Oct 30, 2008
Appl. No.:
12/261958
Inventors:
Mariusz Ratajczak - Louisville KY, US
Magdalena Kucia - Louisville KY, US
Janina Ratajczak - Louisville KY, US
Denis O. Rodgerson - Malibu CA, US
George S. Smith - Pacific Palisades CA, US
Roberto Bolli - Louisville KY, US
Ronald E. Allen - Woodland Hills CA, US
Wayne A. Marasco - Wellesley MA, US
Magdalena Kucia - Louisville KY, US
Janina Ratajczak - Louisville KY, US
Denis O. Rodgerson - Malibu CA, US
George S. Smith - Pacific Palisades CA, US
Roberto Bolli - Louisville KY, US
Ronald E. Allen - Woodland Hills CA, US
Wayne A. Marasco - Wellesley MA, US
International Classification:
A61K 35/12, C12N 5/00, A61P 17/02, A61P 9/00
US Classification:
424 937, 435374
Abstract:
The presently disclosed subject matter provides populations of stem cells that are purified from bone marrow, peripheral blood, and/or other sources. Also provided are methods of using the stem cells for treating tissue and/or organ damage in a subject.
Uses And Isolation Of Very Small Embryonic-Like (Vsel) Stem Cells
US Patent:
2011018, Aug 4, 2011
Filed:
Oct 30, 2008
Appl. No.:
12/740718
Inventors:
Mariusz Ratajczak - Louisville KY, US
Magdalena Kucia - Louisville KY, US
Janina Ratajczak - Louisville KY, US
George Smith - Pacific Palisades CA, US
Ronald Allen - Woodlands Hills CA, US
Wayne Marasco - Wellesley MA, US
Roberto Bolli - Louisville KY, US
Magdalena Kucia - Louisville KY, US
Janina Ratajczak - Louisville KY, US
George Smith - Pacific Palisades CA, US
Ronald Allen - Woodlands Hills CA, US
Wayne Marasco - Wellesley MA, US
Roberto Bolli - Louisville KY, US
International Classification:
A61K 35/12, C12N 5/02, A61K 38/18, A61B 10/00
US Classification:
424 937, 435374, 514 76, 600562
Abstract:
The presently disclosed subject matter provides populations of stem cells that are purified from bone marrow, peripheral blood, and/or other sources. Also provided are methods of using the stem cells for treating tissue and/or organ damage in a subject.